Hagen Cramer

Company: QurAlis Corp.

Job title: Chief Technology Officer

Seminars:

9:00 am Workshop B: Optimizing the Oligonucleotide Structure: Unravelling the Role of Linkage & Sugar Modifications in CNS Therapeutics 9:00 am

Given the pivotal role of linkages and sugars in the development of oligonucleotide developments for CNS, this workshop will explore the latest advancements, challenges and strategies to enhance the safety and efficacy of CNS-targeted siRNAs, ASOs and RNA aptamers. Join this session to: Alter accessibility of 3’ and 5’ ends to create transient shapes improving…Read more

day: Pre-Conference Workshop Day - Track B P1